Brands and Their Owners
Welcome to the Brand page for “AYRLIMA”, which is offered here for Pharmaceutical preparations for the prevention and treatment of chronic idiopathic urticaria; pharmaceutical preparations and substances for treatment and/or alleviation of rhinitis; pharmaceutical preparations and substances for treatment and/or alleviation of asthma; pharmaceutical preparations and substances for treatment and/or alleviation of respiratory ailments and chronic obstructive pulmonary disease; inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments and chronic obstructive pulmonary disease; pharmaceutical preparations and substances for treatment and/or alleviation of ige-mediated disorders; pharmaceutical preparations and substances for treatment and/or alleviation of atopic dermatitis; pharmaceutical preparations and substances for treatment and/or alleviation of psoriasis, psoriatic arthritis, rheumatoid arthritis and other musculoskeletal disorders; pharmaceutical preparations and substances for treatment and/or alleviation of systemic lupus erythematosus;.
Its status is currently believed to be active. Its class is unavailable. “AYRLIMA” is believed to be currently owned by “Glenmark Specialty S.A.”
Owner: |
GLENMARK SPECIALTY S.A.
Owner Details |
---|---|
Description: |
Pharmaceutical preparations for the prevention and treatment of Chronic Idiopathic Urticaria; Pharmaceutical preparations and substances for treatment and/or alleviation of Rhinitis; Pharmaceutical preparations and substances for treatment and/or alleviation of Asthma; Pharmaceutical preparations and substances for treatment and/or alleviation of respiratory ailments and Chronic Obstructive Pulmonary Disease; Inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments and Chronic Obstructive Pulmonary Disease; Pharmaceutical preparations and substances for treatment and/or alleviation of IGE-mediated disorders; Pharmaceutical preparations and substances for treatment and/or alleviation of Atopic Dermatitis; Pharmaceutical preparations and substances for treatment and/or alleviation of Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis and other musculoskeletal disorders; Pharmaceutical preparations and substances for treatment and/or alleviation of Systemic Lupus Erythematosus;
|
Categories: | PHARMACEUTICAL PREPARATIONS PREVENTION |